To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Canadian drug maker raises C$45m Series C round
Japanese pharmaceutical company Mitsubishi Tanabe Pharma has led a funding round for Cytochroma that included contributions from Canadian pension La Caisse de dépôt et placement du Québec, Canadian government-backed BDC Capital and four retail venture capital funds.
